{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Ebolavirus",
      "Oligonucleotides",
      "PCR primer",
      "Therapeutic oligonucleotide",
      "Zoonotic virus"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34493367",
  "DateCompleted": {
    "Year": "2021",
    "Month": "09",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "09",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "08",
        "Day": "06"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.gene.2020.100038",
      "S2590-1583(20)30012-7"
    ],
    "Journal": {
      "ISSN": "1879-0038",
      "JournalIssue": {
        "Volume": "763S",
        "PubDate": {
          "Year": "2020",
          "Month": "Dec"
        }
      },
      "Title": "Gene",
      "ISOAbbreviation": "Gene"
    },
    "ArticleTitle": "Time-series analyses of directional sequence changes in SARS-CoV-2 genomes and an efficient search method for candidates for advantageous mutations for growth in human cells.",
    "Pagination": {
      "StartPage": "100038",
      "MedlinePgn": "100038"
    },
    "Abstract": {
      "AbstractText": [
        "We first conducted time-series analysis of mono- and dinucleotide composition for over 10,000 SARS-CoV-2 genomes, as well as over 1500 Zaire ebolavirus genomes, and found clear time-series changes in the compositions on a monthly basis, which should reflect viral adaptations for efficient growth in human cells. We next developed a sequence alignment free method that extensively searches for advantageous mutations and rank them in an increase level for their intrapopulation frequency. Time-series analysis of occurrences of oligonucleotides of diverse lengths for SARS-CoV-2 genomes revealed seven distinctive mutations that rapidly expanded their intrapopulation frequency and are thought to be candidates of advantageous mutations for the efficient growth in human cells."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 The Authors. Published by Elsevier B.V. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioscience, Nagahama Institute of Bio-Science and Technology, Tamura-cho 1266, Nagahama-shi, Shiga-ken 526-0829, Japan."
          }
        ],
        "LastName": "Wada",
        "ForeName": "Kennosuke",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioscience, Nagahama Institute of Bio-Science and Technology, Tamura-cho 1266, Nagahama-shi, Shiga-ken 526-0829, Japan."
          }
        ],
        "LastName": "Wada",
        "ForeName": "Yoshiko",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Bioscience, Nagahama Institute of Bio-Science and Technology, Tamura-cho 1266, Nagahama-shi, Shiga-ken 526-0829, Japan. Electronic address: t_ikemura@nagahama-i-bio.ac.jp."
          }
        ],
        "LastName": "Ikemura",
        "ForeName": "Toshimichi",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Gene",
    "NlmUniqueID": "7706761",
    "ISSNLinking": "0378-1119"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Oligonucleotides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Oligonucleotides"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sequence Alignment"
    }
  ],
  "CoiStatement": "Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}